(Total Views: 466)
Posted On: 05/15/2025 11:50:08 AM
Post# of 154853

In all the recent excitement of ESMO
It is easy to forget about Dr. Jonah Sacha’s work at OSHU, or that leronlimab showed reversal of liver fibrosis. There are so many great things ahead of us in my opinion. That being said I think this stock is extremely undervalued and will accelerate at some point soon.
Just my opinion based on everything that is currently in the works
It is easy to forget about Dr. Jonah Sacha’s work at OSHU, or that leronlimab showed reversal of liver fibrosis. There are so many great things ahead of us in my opinion. That being said I think this stock is extremely undervalued and will accelerate at some point soon.
Just my opinion based on everything that is currently in the works

